Dr. Punit Srivastava

Dr. Punit Srivastava serves as the Director and Chief Scientific Officer at MediCeption Science Pvt Ltd since January 2016, overseeing clinical trial support services, regulatory studies, medico-marketing, and market research activities, managing over 50 projects for leading pharmaceutical companies. Prior to this role, Dr. Srivastava worked at Daiichi Sankyo, Inc. from July 2010 to December 2016 as Assistant Director, leading projects in respiratory inflammation, autoimmune disorders, and infectious diseases. Additionally, Dr. Srivastava held the position of Group Leader at Ranbaxy Research Laboratories from October 2004 to June 2010, where significant contributions were made in similar therapeutic areas, including the identification of a molecule currently being evaluated in Phase II clinical trials for COPD. Early career experience includes serving as a Senior Research Fellow at the University of Connecticut and a post-doctoral fellowship in pharmacology and toxicology at the Medical College of Wisconsin. Academic credentials include a Doctorate in Pharmacology from Banaras Hindu University.